27 02 2015

Valeant To Acquire Salix Pharmaceuticals for $14.5 Billion

Willkie has advised Centerview Partners acting as Financial Advisor to Salix


Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. announced they have entered into a definitive agreement for Valeant to acquire Salix for $14.5 billion. Willkie represented Centerview Partners, which served as a financial advisor to Salix, a leader in the gastrointestinal market. The agreement calls for Valeant, a developer, manufacturer and marketer of a broad range of pharmaceutical products, to acquire all of the outstanding common stock of Salix for $158.00 per share in cash. The transaction was approved by the Boards of Directors of both companies, and is expected to yield more than $500 million in annual cost savings for the combined company. It is expected to close in the second quarter of 2015. The Willkie deal team was led by partner Steven Seidman (Picture) and included partner Laura Delanoy and associate Laura Acker. Involved fees earner: Steven Seidman - Willkie Farr & Gallagher; Laura Delanoy - Willkie Farr & Gallagher; Laura Acker - Willkie Farr & Gallagher;

LATEST ISSUE
LE FONTI LEGAL
Powered by Share Trading

POPULAR ARTICLES
LE FONTI AWARDS - AWARDING WORLDWIDE CORPORATE EXCELLENCE IN INNOVATION

09/05/2018

LE FONTI AWARDS - AWARDING WORLDWIDE CORPORATE EXCELLENCE IN INNOVATION Read about le

LE FONTI AWARDS 2018 CELEBRATES CORPORATE EXCELLENCES IN HONG KONG

29/03/2018

On March 23rd 2018, the world’s leading corporate stars reunited for a special

LE FONTI AWARDS 2017 CELEBRATES CORPORATE EXCELLENCES IN DUBAI

14/12/2017

On December 14th, 2017, the world’s leading corporate stars reunited for a spec

LE FONTI AWARDS 2017 CELEBRATE CORPORATE EXCELLENCES IN LONDON

23/10/2017

On October 20th, 2017, the world’s leading corporate stars reunited for a speci

Le Fonti IAIR Awards Take Hong Kong By Storm

21/03/2017

Hong Kong has become a city of bright expansion, culture, and futuristic innovation. Fr